Form 6-K CASCADES INC For: Aug 05

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

August 5, 2016 12:28 PM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

__________

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August, 2016

 

Commission File Number 333-105024

__________

 

 

CASCADES INC.

 

404 Marie-Victorin Blvd.

Kingsey Falls, Quebec

Canada J0A 1B0

(Address of registrant's principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☐ Form 40-F ☒  

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):___

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):___

 

 

 
 

 

This Report of Foreign Private Issuer on Form 6-K is being furnished to the Securities and Exchange Commission by Cascades Inc. (the “Company”) for the purpose of providing the press release issued by the Company on August 5, 2016, a copy of which is filed as Exhibit 99.1 hereto and incorporated herein by reference.

Exhibit Number   Document
99.1 Press Release dated August 5, 2016
   

 

 
 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CASCADES INC.
   
   
  By: /s/ Louise Paul
  Name:   Louise Paul
  Title:  Corporate Assistant Secretary
 
   
Date: August 5, 2016  

 

 

 
 

 

Exhibit Index

 

 

Exhibit Number   Document
99.1 Press Release dated August 5, 2016
   

 

 

 

 

 

Exhibit 99.1

 



 
PRESS RELEASE
Cascades Inc.
404 Marie-Victorin Blvd., P.O. Box 30
Kingsey Falls (Québec) Canada J0A 1B0
www.cascades.com
Telephone: 819-363-5100
Fax: 819-363-5155

Cascades Continues to Improve its Results for the Second Quarter of 2016

Kingsey Falls, Quebec, August 5, 2016 - Cascades Inc. (TSX: CAS), a leader in the recovery and manufacturing of green packaging and tissue paper products, is pleased to announce its unaudited financial results for the three-month period ended June 30, 2016.

Q2 2016 Highlights
•
Sales of $998 million
(compared to $1,003 million in Q1 2016 (0%) and $950 million in Q2 2015 (+5%))
•
Excluding specific items
◦
OIBD of $112 million
(compared to $106 million in Q1 2016 (+6%) and $103 million in Q2 2015 (+9%))
◦
Net earnings per common share of $0.38
(compared to $0.35 in Q1 2016 and $0.25 in Q2 2015)
◦
Greenpac contribution to net earnings per common share: $0.03
(compared to $0.04 in Q1 2016 and $0.03 in Q2 2015)
•
Including specific items
◦
OIBD of $112 million
(compared to $120 million in Q1 2016 (-7%) and $105 million in Q2 2015 (+7%))
◦
Net earnings per common share of $0.38
(compared to $0.79 in Q1 2016 and $0.25 in Q2 2015)
•
Net debt of $1,664 million as at June 30, 2016 (compared to $1,684 million as at March 31, 2016) and net debt to OIBD ratio down from 3.8x to 3.6x
        
    
Mr. Mario Plourde, President and Chief Executive Officer, commented on the second quarter results: “We are pleased with the overall performance of our operations during the second quarter. Results in North America were in line with expectations, and highlight how our strategic investment in new equipment over the last few years is translating into improved efficiency, and a greater operational capacity to adapt to changing market dynamics.

We made important headway this quarter, and completed several relevant transactions. The first was in our Containerboard Packaging Group, which acquired a corrugated packaging plant in Connecticut. The move strengthens our position in the Northeastern United States by increasing our converting capacity, while also providing us with the platform to execute our longer-term development strategy of upgrading our asset base and growing our presence in this area. Our Tissue Products Group also announced plans to build a new converting plant in Oregon that will house state-of-the-art converting lines, slated to begin operating at the end of the first quarter of next year. In addition to providing us with a new strategically positioned base to service the Western US market, this new facility will be fed by our nearby mill, providing secured off-take for this operation and increasing our overall integration rate in Tissue.

As for our financial results, the 9% increase in OIBD compared to 2015, was largely driven by the strong performance of our Tissue Papers Group, which increased its OIBD by 70%. In addition, our Containerboard Packaging and Specialty Products Groups also had a strong performance and successfully increased their OIBD by 9% and 14%, respectively. Quarterly sales and OIBD levels in North America benefited from a 5% decrease in the value of the Canadian dollar against the US dollar. The results of our European division were slightly weaker for the quarter, largely due to the ongoing challenging market dynamics, as well as some scheduled downtime at our German mill. On a sequential basis, consolidated OIBD increased 6% as each of our business segments improved their contribution.

Finally, we continue to work on our debt reduction objective. Sequentially, the decrease in our debt was mainly the result of stronger cash flows from operations which were partially utilized to make seasonal investments in working capital and capital investments. Our net debt to OIBD ratio now stands at 3.6x, bringing us closer to our targeted range of 3.0x to 3.5x.”




Financial Summary

Segmented OIBD excluding specific items 1 
(in millions of Canadian dollars) (unaudited)
Q2 2016

Q1 2016

Q2 2015

 
 
 
 
Packaging Products
 
 
 
Containerboard
60

55

55

Boxboard Europe
17

16

19

Specialty Products
16

14

14


 
 
 
Tissue Papers
39

34

23


 
 
 
Corporate Activities
(20
)
(13
)
(8
)
OIBD excluding specific items
112

106

103

1 - Refer to the “Supplemental Information on Non-IFRS Measures” section.
 
 
 

Selected consolidated information
(in millions of Canadian dollars, except amounts per share) (unaudited)
Q2 2016

Q1 2016

Q2 2015

 
 
 
 
Sales
998

1,003

950

Excluding specific items1
 
 
 
Operating income before depreciation and amortization (OIBD)
112

106

103

Operating income
65

59

59

Net earnings
35

34

24

per common share
$
0.38

$
0.35

$
0.25

Margin (OIBD)
11.2
%
10.6
%
10.8
%
As reported
 
 
 
Operating income before depreciation and amortization (OIBD)
112

120

105

Operating income
65

73

61

Net earnings
36

75

24

per common share
$
0.38

$
0.79

$
0.25

1 - Refer to the “Supplemental Information on Non-IFRS Measures” section.
 
 
 


Analysis of results for the three-month period ended June 30, 2016 (compared to the same period last year)

Sales increased by 5% to $998 million compared to the same period last year, reflecting higher average selling prices combined with the positive financial impact of the lower Canadian dollar.

Operating income, excluding specific items, increased from $59 million in the second quarter of 2015 to $65 million in the second quarter of 2016. This improvement is attributable to the above-mentioned factors and favorable energy costs. Partially offsetting these benefits were higher corporate costs as well as production and maintenance costs, in addition to some production downtimes that were taken during the quarter, most notably at our recycled boxboard plant in Germany where we upgraded a section of the machine. When including specific items, operating income amounted to $65 million compared to $61 million for the same period last year.

In the second quarter of 2016, the main specific items, before income taxes, that impacted our operating income and/or net earnings were:
•
a $5 million unrealized gain on derivative financial instruments (operating income and net earnings);
•
a $9 million impairment and restructuring charge (operating income and net earnings);
•
a $4 million gain on the sale of assets following the closure of the Auburn, Maine, plant (operating income and net earnings);
•
a $6 million loss on share of results of associated and joint ventures on our portion of the Greenpac refinancing fees (net earnings);
•
a $6 million foreign exchange gain on long-term debt and financial instruments (net earnings);
•
a $2 million income tax expense related to assets sales in past years (net earnings).

Net earnings excluding specific items amounted to $35 million ($0.38 per share) in the second quarter of 2016 compared to $24 million ($0.25 per share) for the same period in 2015. Including specific items, net earnings amounted to $36 million ($0.38 per share) in the second quarter of 2016 compared to $24 million ($0.25 per share) in the same period in 2015.






Analysis of results for the three-month period ended June 30, 2016 (compared to the previous quarter)

On a sequential basis, sales remained relatively stable at $998 million, as higher shipments in all segments except Boxboard Europe were offset by the strengthening of the Canadian dollar and a decrease in our average selling prices, mainly in our tissue activities.

Operating income, excluding specific items, increased from $59 million in the first quarter of 2016 to $65 million in the second quarter of 2016. This improvement is attributable to a combination of the factors mentioned above and lower energy costs, which were slightly counterbalanced by higher depreciation expense and corporate costs.

For further details, see the tables on IFRS and non-IFRS measures reconciliation, included herewith.

Near-Term Outlook

Commenting on the near-term outlook for Cascades, Mr. Plourde added: “We are committed to delivering a solid operational performance through the end of 2016. Despite recent North American price decreases in Containerboard and the volatility in regards to fibre costs and the Canadian dollar, we expect that our Containerboard Packaging and Specialty products Groups will perform well through the third quarter, which is a seasonally strong period for these operations. In regards to our Tissue Group, we anticipate that sales and cost reduction initiatives will translate into a solid performance through the seasonally strong third quarter, followed by a cyclically softer fourth quarter. In Europe, we expect market conditions to remain soft, and order intake to continue to lag last year’s levels, with additional market and exchange rate uncertainty following recent events in different parts of Europe. While the fourth quarter is a cyclically slower period, the increased generation of waste paper following the end of summer vacations should contribute to positive supply dynamics and our sourcing teams are focused on the strategic management of our input material in order to reduce delivered cost to our mills.

In the near-term, we do not expect our third quarter results to match the record performance we achieved during the third quarter of last year, but we will continue to carefully manage our financial situation in order to direct a significant portion of our free cash flow to debt reduction, which is normally the case in the second half of the year. Longer-term, we remain committed to improving the efficiency and competitiveness of our operations through strategic investments, and the successful execution of our strategic action plan. By doing so, we will continue to build on our capacity to adapt to market dynamics, reinforce our operational foundation, and deliver improved productivity and overall performance. ”

Dividend on common shares and normal course issuer bid

The Board of Directors of Cascades declared a quarterly dividend of $0.04 per share to be paid September 2, 2016, to shareholders of record at the close of business on August 26, 2016. This dividend paid by Cascades is an “eligible dividend” as per the Income Tax Act (Bill C-28, Canada).

In the second quarter of 2016, Cascades purchased for cancellation 315,069 shares at an average price of $8.56 representing an aggregate amount of approximately $2.7 million.

Conference call information

Management will discuss the financial results for the second quarter of 2016 during a conference call to be held today at 10:00 a.m. EST.

The call can be accessed by dialing 1-888-231-8191. The conference call, including the investor presentation, will also be broadcast live on the Cascades corporate website (www.cascades.com, Investors tab on the Home page). The broadcast replay will be available on the Cascades corporate website and by phone until September 5, 2016 by dialing 1-855-859-2056 and by using the access code 42826663.


Founded in 1964, Cascades produces, converts and markets packaging and tissue products that are composed mainly of recycled fibres. The Corporation employs 11,000 employees, who work in close to 90 units located in North America and Europe. With its management philosophy, half a century of experience in recycling, and continuous efforts in research and development as driving forces, Cascades continues to serve its clients with innovative products. Cascades' shares trade on the Toronto Stock Exchange, under the ticker symbol CAS.

Certain statements in this release, including statements regarding future results and performance, are forward-looking statements (as such term is defined under the Private Securities Litigation Reform Act of 1995) based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for the Corporation's products, increases in raw material costs, fluctuations in selling prices and adverse changes in general market and industry conditions and other factors listed in the Corporation's Securities and Exchange Commission filings.






CONSOLIDATED BALANCE SHEETS

(in millions of Canadian dollars) (unaudited)
June 30, 2016

December 31, 2015

Assets


Current assets


Cash and cash equivalents
29

60

Accounts receivable
599

540

Current income tax assets
13

30

Inventories
487

494

Financial assets
1

1

 
1,129

1,125

Long-term assets


Investments in associates and joint ventures
308

322

Property, plant and equipment
1,583

1,608

Intangible assets with finite useful life
174

174

Financial assets
16

12

Other assets
43

80

Deferred income tax assets
179

181

Goodwill and other intangible assets with indefinite useful life
348

346

 
3,780

3,848

Liabilities and Equity


Current liabilities


Bank loans and advances
34

37

Trade and other payables
591

613

Current income tax liabilities
1

1

Current portion of long-term debt
34

34

Current portion of provisions for contingencies and charges
11

5

Current portion of financial liabilities and other liabilities
13

37

 
684

727

Long-term liabilities


Long-term debt
1,625

1,710

Provisions for contingencies and charges
32

34

Financial liabilities
35

47

Other liabilities
189

178

Deferred income tax liabilities
198

189

 
2,763

2,885

Equity attributable to Shareholders


Capital stock
486

490

Contributed surplus
16

17

Retained earnings
463

387

Accumulated other comprehensive loss
(40
)
(27
)
 
925

867

Non-controlling interest
92

96

Total equity
1,017

963

 
3,780

3,848











CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
 
For the 3-month periods ended June 30,
 
For the 6-month periods ended June 30,
 
(in millions of Canadian dollars, except per-common share amounts and number of common shares) (unaudited)
2016

2015

2016

2015

Sales
998

950

2,001

1,860

Cost of sales and expenses






Cost of sales (including depreciation and amortization of $47 million for 3-month period (2015 — $44 million) and $94 million for 6-month period (2015 — $88 million))
834

801

1,680

1,585

Selling and administrative expenses
98

88

191

174

Gain on acquisitions, disposals and others
(4
)
—

(4
)
—

Impairment charges and restructuring costs
9

4

9

4

Foreign exchange loss (gain)
(1
)
—

—

(2
)
Loss (gain) on derivative financial instruments
(3
)
(4
)
(13
)
10


933

889

1,863

1,771

Operating income
65

61

138

89

Financing expense
20

23

44

47

Interest expense on employee future benefits
2

1

3

3

Loss on refinancing of long-term debt
—

19

—

19

Foreign exchange loss (gain) on long-term debt and financial instruments
(6
)
(13
)
(42
)
32

Share of results of associates and joint ventures
(1
)
(5
)
(15
)
(9
)
Earnings (loss) before income taxes
50

36

148

(3
)
Provision for income taxes
13

8

34

4

Net earnings (loss) from continuing operations including non-controlling interest for the period
37

28

114

(7
)
Net loss from discontinued operations
—

(2
)
—

—

Net earnings (loss) including non-controlling interest for the period
37

26

114

(7
)
Net earnings attributable to non-controlling interest
1

2

3

4

Net earnings (loss) attributable to Shareholders for the period
36

24

111

(11
)
Net earnings (loss) from continuing operations per common share








     Basic
$
0.38

$
0.27

$
1.17

$
(0.12
)
     Diluted
$
0.37

$
0.27

$
1.14

$
(0.12
)
Net earnings (loss) per common share








     Basic
$
0.38

$
0.25

$
1.17

$
(0.12
)
     Diluted
$
0.37

$
0.25

$
1.14

$
(0.12
)
Weighted average basic number of common shares outstanding
94,596,934

94,232,625

94,969,656

94,216,756

Weighted average number of diluted common shares
96,463,392

95,590,059

96,985,595

95,807,546






Net earnings (loss) attributable to Shareholders:






     Continuing operations
36

26

111

(11
)
     Discontinued operations
—

(2
)
—

—

Net earnings (loss)
36

24

111

(11
)
















CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

 
For the 3-month periods ended June 30,
 
For the 6-month periods ended June 30,
 
(in millions of Canadian dollars) (unaudited)
2016

2015

2016

2015

Net earnings (loss) including non-controlling interest for the period
37

26

114

(7
)
Other comprehensive income (loss)




Items that may be reclassified subsequently to earnings




Translation adjustments




Change in foreign currency translation of foreign subsidiaries
(10
)
(5
)
(55
)
40

Change in foreign currency translation related to net investment hedging activities
7

8

45

(40
)
Income taxes
(1
)
(1
)
(6
)
5

Cash flow hedges




Change in fair value of foreign exchange forward contracts
—

1

—

2

Change in fair value of interest rate swaps
(2
)
4

(7
)
8

Change in fair value of commodity derivative financial instruments
7

(1
)
6

1

Income taxes
(1
)
1

1

(4
)
Available-for-sale financial assets
(1
)
—

(2
)
2


(1
)
7

(18
)
14

Items that are reclassified to retained earnings




Actuarial gain (loss) on post-employment benefit obligations
(15
)
9

(34
)
10

Income taxes
4

(3
)
9

(3
)
(11
)
6

(25
)
7

Other comprehensive income (loss)
(12
)
13

(43
)
21

Comprehensive income including non-controlling interest for the period
25

39

71

14

Comprehensive income (loss) attributable to non-controlling interest for the period
(2
)
4

(2
)
3

Comprehensive income attributable to Shareholders for the period
27

35

73

11

Comprehensive income (loss) attributable to Shareholders:




Continuing operations
27

37

73

11

Discontinued operations
—

(2
)
—

—

Comprehensive income
27

35

73

11

























CONSOLIDATED STATEMENTS OF EQUITY
 
For the 6-month period ended June 30, 2016
 
(in millions of Canadian dollars) (unaudited)
CAPITAL STOCK

CONTRIBUTED SURPLUS

RETAINED EARNINGS

ACCUMULATED OTHER COMPREHENSIVE LOSS

TOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS

NON-CONTROLLING INTEREST

TOTAL EQUITY

Balance - Beginning of period
490

17

387

(27
)
867

96

963

Comprehensive income (loss)








Net earnings
—

—

111

—

111

3

114

Other comprehensive loss
—

—

(25
)
(13
)
(38
)
(5
)
(43
)
—

—

86

(13
)
73

(2
)
71

Dividends
—

—

(8
)
—

(8
)
—

(8
)
Stock options
—

1

—

—

1

—

1

Redemption of common shares
(4
)
(2
)
(2
)
—

(8
)
—

(8
)
Dividends paid to non-controlling interest
—

—

—

—

—

(2
)
(2
)
Balance - End of period
486

16

463

(40
)
925

92

1,017

 
 
 
 
 
 
 
 
 
For the 6-month period ended June 30, 2015
 
(in millions of Canadian dollars) (unaudited)
CAPITAL STOCK

CONTRIBUTED SURPLUS

RETAINED EARNINGS

ACCUMULATED OTHER COMPREHENSIVE LOSS

TOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS

NON-CONTROLLING INTEREST

TOTAL EQUITY

Balance - Beginning of period
483

18

454

(62
)
893

110

1,003

Comprehensive income (loss)








Net earnings (loss)
—

—

(11
)
—

(11
)
4

(7
)
Other comprehensive income (loss)
—

—

8

14

22

(1
)
21


—

—

(3
)
14

11

3

14

Dividends
—

—

(8
)
—

(8
)
—

(8
)
Stock options
1

1

—

—

2

—

2

Balance - End of period
484

19

443

(48
)
898

113

1,011




















CONSOLIDATED STATEMENTS OF CASH FLOWS
 
For the 3-month periods ended June 30,
 
For the 6-month periods ended June 30,
 
(in millions of Canadian dollars) (unaudited)
2016

2015

2016

2015

Operating activities from continuing operations






Net earnings (loss) attributable to Shareholders for the period
36

24

111

(11
)
Net loss from discontinued operations
—

2

—

—

Net earnings (loss) from continuing operations
36

26

111

(11
)
Adjustments for:






Financing expense and interest expense on employee future benefits
22

24

47

50

Loss on refinancing of long-term debt
—

19

—

19

Depreciation and amortization
47

44

94

88

Gain on acquisitions, disposals and others
(5
)
—

(5
)
—

Impairment charges and restructuring costs
1

1

1

1

Unrealized loss (gain) on derivative financial instruments
(5
)
(6
)
(19
)
7

Foreign exchange loss (gain) on long-term debt and financial instruments
(6
)
(13
)
(42
)
32

Provision for income taxes
13

8

34

4

Share of results of associates and joint ventures
(1
)
(5
)
(15
)
(9
)
Net earnings attributable to non-controlling interest
1

2

3

4

Net financing expense paid
(3
)
(12
)
(47
)
(56
)
Premium paid on long-term debt refinancing
—

(13
)
—

(13
)
Net income taxes received (paid)
7

(2
)
8

(7
)
Dividend received
6

2

9

4

Employee future benefits and others
(6
)
(5
)
(16
)
(8
)
107

70

163

105

Changes in non-cash working capital components
(26
)
(21
)
(59
)
(47
)
81

49

104

58

Investing activities from continuing operations






Investments in associates and joint ventures
(2
)
—

(2
)
—

Payments for property, plant and equipment
(47
)
(47
)
(102
)
(82
)
Proceeds on disposals of property, plant and equipment
1

1

2

1

Change in intangible and other assets
12

(2
)
10

(3
)
Business acquisition
(15
)
—

(15
)
—


(51
)
(48
)
(107
)
(84
)
Financing activities from continuing operations






Bank loans and advances
—

(14
)
(2
)
(20
)
Change in revolving credit facilities
(53
)
10

4

11

Issuance of senior notes, net of related expenses
—

300

—

300

Repayment of senior notes
—

(305
)
—

(305
)
Increase in other long-term debt
14

27

15

28

Payments of other long-term debt
(21
)
(15
)
(26
)
(21
)
Redemption of common shares
(3
)
1

(8
)
1

Dividends paid to non-controlling interest
(1
)
—

(1
)
—

Dividends paid to the Corporation's Shareholders
(4
)
(4
)
(8
)
(8
)
(68
)
—

(26
)
(14
)
Change in cash and cash equivalents during the period from continuing operations
(38
)
1

(29
)
(40
)
Change in cash and cash equivalents during the period from discontinued operations
—

(5
)
—

36

Net change in cash and cash equivalents during the period
(38
)
(4
)
(29
)
(4
)
Currency translation on cash and cash equivalents
(1
)
—

(2
)
(1
)
Cash and cash equivalents - Beginning of period
68

28

60

29

Cash and cash equivalents - End of period
29

24

29

24





SEGMENTED INFORMATION
The Corporation analyzes the performance of its operating segments based on their operating income before depreciation and amortization, which is not a measure of performance under International Financial Reporting Standards (“IFRS”); however, the chief operating decision-maker (“CODM”) uses this performance measure to assess the operating performance of each reportable segment. Earnings for each segment are prepared on the same basis as those of the Corporation. Intersegment operations are recorded on the same basis as sales to third parties, which are at fair market value. The accounting policies of the reportable segments are the same as the Corporation's accounting policies described in its most recent audited consolidated financial statements for the year ended December 31, 2015.
The Corporation's operating segments are reported in a manner consistent with the internal reporting provided to the CODM. The Chief Executive Officer has authority for resource allocation and assessment of the Corporation's performance, and is therefore the CODM.
The Corporation's operations are managed in four segments: Containerboard, Boxboard Europe, Specialty Products (which constitutes the Packaging Products of the Corporation) and Tissue Papers.
 
SALES
 
 
For the 3-month periods ended June 30,
 
For the 6-month periods ended June 30,
 
(in millions of Canadian dollars) (unaudited)
2016

2015

2016

2015

Packaging Products




Containerboard
342

322

678

622

Boxboard Europe
197

202

416

418

Specialty Products
157

146

306

281

Intersegment sales
(14
)
(13
)
(29
)
(25
)
682

657

1,371

1,296

Tissue Papers
324

299

644

573

Intersegment sales and others
(8
)
(6
)
(14
)
(9
)
998

950

2,001

1,860



 
OPERATING INCOME (LOSS)
BEFORE DEPRECIATION AND AMORTIZATION (OIBD)
 
 
For the 3-month periods ended June 30,
 
For the 6-month periods ended June 30,
 
(in millions of Canadian dollars) (unaudited)
2016

2015

2016

2015

Packaging Products




Containerboard
60

55

115

107

Boxboard Europe
15

17

31

34

Specialty Products
20

14

34

24


95

86

180

165

Tissue Papers
33

23

67

38

Corporate
(16
)
(4
)
(15
)
(26
)
Operating income before depreciation and amortization
112

105

232

177

Depreciation and amortization
(47
)
(44
)
(94
)
(88
)
Financing expense and interest expense on employee future benefits
(22
)
(24
)
(47
)
(50
)
Loss on refinancing of long-term debt
—

(19
)
—

(19
)
Foreign exchange gains (loss) on long-term debt and financial instruments
6

13

42

(32
)
Share of results of associates and joint ventures
1

5

15

9

Earnings (loss) before income taxes
50

36

148

(3
)












 
PAYMENTS FOR PROPERTY, PLANT AND EQUIPMENT
 
 
For the 3-month periods ended June 30,
 
For the 6-month periods ended June 30,
 
(in millions of Canadian dollars) (unaudited)
2016

2015

2016

2015

Packaging Products




Containerboard
9

12

25

18

Boxboard Europe
9

4

13

6

Specialty Products
4

2

12

4


22

18

50

28

Tissue Papers
22

19

33

39

Corporate
6

3

17

4

Total acquisitions
50

40

100

71

Proceeds on disposals of property, plant and equipment
(1
)
(1
)
(2
)
(1
)
Capital-lease acquisitions and included in other debts
(4
)
3

(11
)
—


45

42

87

70

Acquisitions of property, plant and equipment included in ''Trade and other payables''




Beginning of period
8

13

20

20

End of period
(7
)
(9
)
(7
)
(9
)
Payments for property, plant and equipment net of proceeds on disposals
46

46

100

81



SUPPLEMENTAL INFORMATION ON NON-IFRS MEASURES

Operating income before depreciation and amortization, earnings before interest, income taxes, depreciation and amortization and operating income are not measures of performance under IFRS. The Corporation includes operating income before depreciation and amortization, earnings before interest, taxes, depreciation and amortization and operating income because they are measures used by management to assess the operating and financial performance of the Corporation's operating segments. Additionally, the Corporation believes that these items provide additional measures often used by investors to assess a company's operating performance and its ability to meet debt service requirements. However, operating income before depreciation and amortization, earnings before interest, taxes, depreciation and amortization and operating income do not represent, and should not be used as a substitute for, net earnings or cash flows from operating activities as determined in accordance with IFRS, and they are not necessarily an indication of whether cash flow will be sufficient to fund our cash requirements. In addition, our definition of operating income before depreciation and amortization, earnings before interest, taxes, depreciation and amortization and operating income may differ from those of other companies.

Operating income before depreciation and amortization excluding specific items, earnings before interest, income taxes, depreciation and amortization excluding specific items, operating income excluding specific items, net earnings excluding specific items and net earnings per common share excluding specific items are non-IFRS measures. The Corporation believes that it is useful for investors to be aware of specific items that have adversely or positively affected its IFRS measures, and that the above mentioned non-IFRS measures provide investors with a measure of performance with which to compare its results between periods without regard to these specific items. The Corporation's measures excluding specific items have no standardized meaning prescribed by IFRS and are not necessarily comparable to similar measures presented by other companies and therefore should not be considered in isolation.

The specific items excluded from OIBD, operating income, financing expense, net earnings and cash flow from operations mainly include charges for (reversals of) impairment of assets, restructuring gains or costs, loss on refinancing of long-term debt, deferred tax assets provisions or reversals, premiums paid on long-term debt refinancing, gains or losses on the acquisition or sale of a business unit, gains or losses on the share of results of associates and joint ventures, unrealized gains or losses on derivative financial instruments that do not qualify for hedge accounting, unrealized gains or losses on interest rate swaps, foreign exchange gains or losses on long-term debt, specific items of discontinued operations and other significant items of an unusual or non-recurring nature. Although we consider these items to be non-recurring and less relevant to evaluating our performance, some of them might take place in the future and will reduce the cash available to us.











The following table reconciles net earnings and net earnings per common share with net earnings excluding specific items and net earnings per share excluding specific items:
 
(in millions of Canadian dollars, except amounts per share) (unaudited)
Net earnings
 
 
Net earnings per share 1
 
 
Q2 2016

Q1 2016

Q2 2015

 
 
Q2 2016

Q1 2016

Q2 2015

 
 
 
 
 
 
 
 
 
 
 
As per IFRS
36

75

24

 
 
$
0.38

$
0.79

$
0.25

 
Specific items:



 
 



 
Gain on acquisitions, disposals and others
(4
)
—

—

 
 
$
(0.03
)
—

—

 
Impairment charges
3

—

1

 
 
$
0.02

—

—

 
Restructuring costs
6

—

3

 
 
$
0.04

—

$
0.02

 
Unrealized gain on derivative financial instruments
(5
)
(14
)
(6
)
 
 
$
(0.04
)
$
(0.11
)
$
(0.04
)
 
Loss on refinancing of long-term debt
—

—

19

 
 
—

—

$
0.15

 
Foreign exchange gain on long-term debt and financial instruments
(6
)
(36
)
(13
)
 
 
$
(0.05
)
$
(0.33
)
$
(0.12
)
 
Share of results of associates, joint ventures and non-controlling interest
6

—

—

 
 
$
0.04

—

—

 
Included in discontinued operations, net of tax
—

—

(1
)
 
 
—

—

$
(0.01
)
 
Tax effect on specific items, other tax adjustments and attributable to non-controlling interest 1
(1
)
9

(3
)
 
 
$
0.02

—

—

 
 
(1
)
(41
)
—

 
 
—

$
(0.44
)
—

 
Excluding specific items
35

34

24

 
 
$
0.38

$
0.35

$
0.25

 
Note 1 : Specific amounts per common share are calculated on an after-tax basis and are net of the portion attributable to non-controlling interest. Per share amounts in line item ''Tax effect on specific items, other tax adjustments and attributable to non-controlling interest'' only include the effect of tax adjustments.
 


Net earnings, which is a performance measure defined by IFRS, is reconciled below with operating income, operating income excluding specific items and operating income before depreciation excluding specific items or earnings before interest, income taxes, depreciation and amortization excluding specific items:
(in millions of Canadian dollars) (unaudited)
Q2 2016

Q1 2016

Q2 2015

 
 
 
 
Net earnings attributable to Shareholders for the period
36

75

24

Net earnings attributable to non-controlling interest
1

2

2

Net loss from discontinued operations
—

—

2

Provision for income taxes
13

21

8

Share of results of associates and joint ventures
(1
)
(14
)
(5
)
Foreign exchange gain on long-term debt and financial instruments
(6
)
(36
)
(13
)
Financing expense and interest on future employee benefits
22

25

43

Operating income
65

73

61

Specific items :






Gain on acquisitions, disposals and others
(4
)
—

—

Impairment charges
3

—

1

Restructuring costs
6

—

3

Unrealized gain on derivative financial instruments
(5
)
(14
)
(6
)
 
—

(14
)
(2
)
Operating income - excluding specific items
65

59

59

Depreciation and amortization
47

47

44

Operating income before depreciation and amortization (OIBD) - excluding specific items
112

106

103













The following table reconciles the total debt and the net debt with the net debt on operating income before depreciation and amortization (OIBD) excluding specific items ratio:
(in millions of Canadian dollars) (unaudited)
June 30, 2016

December 31, 2015

Long-term debt
1,625

1,710

Current portion of long-term debt
34

34

Bank loans and advances
34

37

Total debt
1,693

1,781

Less : Cash and cash equivalents
29

60

Net debt
1,664

1,721

OIBD excluding specific items on a last twelve months basis
456

426

Net debt / OIBD excluding specific items ratio
3.6

4.0


- 30 -


For further information:
Media:
Source:
Hugo D'Amours
Allan Hogg
Vice-President, Communications and Public Affairs
Vice-President and Chief Financial Officer
819-363-5184

 
Investors:
Follow us on social media:
Jennifer Aitken, MBA
Website: www.cascades.com
Director, Investor Relations
Twitter: twitter.com/@CascadesInvest
514-282-2697
Facebook: facebook.com/Cascades
 
YouTube: youtube.com/Cascades




Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings